Modeling the Prader–Willi Syndrome-Associated Growth Phases in Snord116 KO Mice
- 1Medical Faculty, Core Facility Transgenic Animal and Genetic Engineering Models (TRAM), University of Muenster, Von-Esmarch-Str. 56, 48149 Muenster, Germany
- 2Leibniz Institute on Aging—Fritz Lipmann Institute (FLI), 07745 Jena, Germany
- 3Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany
Abstract
Prader–Willi syndrome (PWS) is a neurodevelopmental disorder characterized by distinctive developmental transition from neonatal hypotonia and poor feeding to progressive weight gain and, later, hyperphagia and obesity. The paternally expressed SNORD116 cluster is critical for postnatal growth, but how its deficiency impacts the progression of PWS remains unclear. Here, we analyzed the day-over-day growth rates for 351 mice with Snord116 deletion or altered Snord116 dosage, including their wild-type littermates, across both sexes and two genetic backgrounds. Snord116 expression increased markedly during early brain development. The Snord116-deficient mice exhibited a distinct three-stage growth trajectory: impaired growth until approximately P16, normalization between P17 and P21, followed by transient accelerated weight gain until approximately P30. Although growth rates subsequently normalized, the accumulated deficit was not fully compensated, and the adult Snord116KO mice remained smaller than the wild-type controls. These developmental transitions broadly parallel the early nutritional phases of human PWS, although the mice did not progress to exhibit persistent obesity-associated growth. Reactivation of the maternal Snord116 cluster partially rescued the growth phenotype, whereas activation of both parental alleles produced a modest growth advantage, which was most evident in the males. These findings identify early postnatal development as a critical window of Snord116-dependent growth regulation and provide a framework for investigating the mechanisms underlying PWS’s progression.
Related
- Loss of Snord115 mitigates Snord116-driven sleep abnormalities in mouse models of Prader-Willi syndrome
- Exploring Sleep Respiratory Endophenotypes in Prader-Willi Syndrome: Impact of Genetic Mutations
- SMCHD1 is a target for gene activation therapy to treat Prader-Willi syndrome
- Magel2 deficiency drives microglial synaptic engulfment and alters neuron-microglia interactions in Prader-Willi syndrome
- A randomized crossover trial with weighted blankets shows improvement in behavior and sleep outcomes in adults with Prader–Willi syndrome
BibTeX
@article{kummerfeld2026modeling,
title = {{Modeling the Prader–Willi Syndrome-Associated Growth Phases in Snord116 KO Mice}},
author = {Delf-Magnus Kummerfeld and Tasneem Khanam and Anna Wolters and Boris V. Skryabin and Timofey S. Rozhdestvensky},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209344},
url = {https://www.mdpi.com/1422-0067/27/20/9344},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Modeling the Prader–Willi Syndrome-Associated Growth Phases in Snord116 KO Mice
AU - Delf-Magnus Kummerfeld
AU - Tasneem Khanam
AU - Anna Wolters
AU - Boris V. Skryabin
AU - Timofey S. Rozhdestvensky
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209344
UR - https://www.mdpi.com/1422-0067/27/20/9344
AB - Prader–Willi syndrome (PWS) is a neurodevelopmental disorder characterized by distinctive developmental transition from neonatal hypotonia and poor feeding to progressive weight gain and, later, hyperphagia and obesity. The paternally expressed SNORD116 cluster is critical for postnatal growth, but how its deficiency impacts the progression of PWS remains unclear. Here, we analyzed the day-over-day growth rates for 351 mice with Snord116 deletion or altered Snord116 dosage, including their wild-type littermates, across both sexes and two genetic backgrounds. Snord116 expression increased markedly during early brain development. The Snord116-deficient mice exhibited a distinct three-stage growth trajectory: impaired growth until approximately P16, normalization between P17 and P21, followed by transient accelerated weight gain until approximately P30. Although growth rates subsequently normalized, the accumulated deficit was not fully compensated, and the adult Snord116KO mice remained smaller than the wild-type controls. These developmental transitions broadly parallel the early nutritional phases of human PWS, although the mice did not progress to exhibit persistent obesity-associated growth. Reactivation of the maternal Snord116 cluster partially rescued the growth phenotype, whereas activation of both parental alleles produced a modest growth advantage, which was most evident in the males. These findings identify early postnatal development as a critical window of Snord116-dependent growth regulation and provide a framework for investigating the mechanisms underlying PWS’s progression.
SN - 1422-0067
ER -